Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorREY, Charlotte
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorNADJAR, Agnes
dc.contributor.authorBUAUD, Benjamin
dc.contributor.authorVAYSSE, Carole
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorAUBERT, Agnes
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorPALLET, Veronique
ORCID: 0000-0002-9078-3269
IDREF: 066841763
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorLAYE, Sophie
ORCID: 0000-0002-3843-1012
IDREF: 11366883X
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorJOFFRE, Corinne
dc.date.accessioned2021-09-08T06:41:24Z
dc.date.available2021-09-08T06:41:24Z
dc.date.issued2016
dc.identifier.issn1090-2139en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112136
dc.description.abstractEnSustained inflammation in the brain together with microglia activation can lead to neuronal damage. Hence limiting brain inflammation and activation of microglia is a real therapeutic strategy for inflammatory disease. Resolvin D1 (RvD1) and resolvin E1 (RvE1) derived from n-3 long chain polyunsaturated fatty acids are promising therapeutic compounds since they actively turn off the systemic inflammatory response. We thus evaluated the anti-inflammatory activities of RvD1 and RvE1 in microglia cells in vitro. BV2 cells were pre-incubated with RvD1 or RvE1 before lipopolysaccharide (LPS) treatment. RvD1 and RvE1 both decreased LPS-induced proinflammatory cytokines (TNF-α, IL-6 and IL-1β) gene expression, suggesting their proresolutive activity in microglia. However, the mechanisms involved are distinct as RvE1 regulates NFκB signaling pathway and RvD1 regulates miRNAs expression. Overall, our findings support that pro-resolving lipids are involved in the resolution of brain inflammation and can be considered as promising therapeutic agents for brain inflammation.
dc.language.isoENen_US
dc.subject.enAnimals
dc.subject.enBV2
dc.subject.enDHA
dc.subject.enDocosahexaenoic Acids
dc.subject.enEicosapentaenoic Acid
dc.subject.enEPA
dc.subject.enInflammation
dc.subject.enInterleukin-6
dc.subject.enMice
dc.subject.enMicroglia
dc.subject.enMicroglial cells
dc.subject.enMicroRNAs
dc.subject.enmiRNA
dc.subject.enn-3 PUFA
dc.subject.enNeuroinflammation
dc.subject.enRvD1
dc.subject.enRvE1
dc.subject.enTumor Necrosis Factor-alpha
dc.title.enResolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.bbi.2015.12.013en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed26718448en_US
bordeaux.journalBrain, Behavior, and Immunityen_US
bordeaux.page249-259en_US
bordeaux.volume55en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.teamPsychoneuroimmunologie et Nutrition: Approches expérimentales et cliniquesen_US
bordeaux.teamNutrition, mémoire et glucocorticoïdesen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Brain,%20Behavior,%20and%20Immunity&rft.date=2016&rft.volume=55&rft.spage=249-259&rft.epage=249-259&rft.eissn=1090-2139&rft.issn=1090-2139&rft.au=REY,%20Charlotte&NADJAR,%20Agnes&BUAUD,%20Benjamin&VAYSSE,%20Carole&AUBERT,%20Agnes&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée